drugset / Trial / NCT01502943
Studies of Traditional Chinese Medicine Clinical Efficacy Evaluation Index
Phase 4
Completed
480 enrolled
Liaoning University of Traditional Chinese Medicine
Ministry of Science and Technology of the People´s Republic of China · collab
RandomizedParallel-groupTriple-blind
Summary
The purpose of the trial is to take stable angina pectoris of coronary heart disease (CHD) as examples to build a standard evaluation system for efficacy of traditional Chinese medicine (TCM). 1. Studies of evaluating reliability, validity and reactivates of Patients Report Outcomes of CHD and self-administrated scale of Stable Angina Pectoris 2. research on all indicators of CHD, and analyze their characteristics, target and function 3. theory of Invigorating Spleen to Remove Phlegm or replenish Qi, and activating blood and dissolving stasis as an example for clinical efficacy evaluation.
Timeline
- Start
- 2011-05
- Primary completion
- 2011-12
- Completion
- 2011-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Chixiangshen Tongxin granules | Unknown | 100 ml | — |
| Subject | Louxiangdan Tongxin granules | Unknown | 100 ml | — |
| Background | Aspirin | Small molecule | 100 mg | Oral |
| Background | Atorvastatin | Small molecule | 10 mg | Oral |
| Background | Clopidogrel | Small molecule | 75 mg | Oral |
| Background | Nitroglycerin | Unknown | — | Other |
| Background | Pravastatin | Small molecule | — | Oral |